Resources Contact Us Home
Browse by: INVENTOR PATENT HOLDER PATENT NUMBER DATE
 
 
Browse by Category: Main > Health & Medicine
Class Information
Number: 514/2
Name: Drug, bio-affecting and body treating compositions > Designated organic active ingredient containing (doai) > Peptide containing (e.g., protein, peptones, fibrinogen, etc.) doai
Description: Subject matter which contains a protein or its reaction product, e.g., peptides, peptones, fibrinogen, etc., wherein the protein molecule is not degraded to the constituent amino-acids.










Sub-classes under this class:

Class Number Class Name Patents
514/14 12 to 15 peptide repeating units in known peptide chain 1,156
514/13 16 to 24 peptide repeating units in known peptide chain 1,207
514/19 2 peptide repeating units in known peptide chain 1,352
514/12 25 or more peptide repeating units in known peptide chain structure 5,904
514/18 3 or 4 peptide repeating units in known peptide chain 1,666
514/17 5 or 6 peptide repeating units in known peptide chain 1,125
514/16 7 or 8 peptide repeating units in known peptide chain 1,087
514/15 9 to 11 peptide repeating units in known peptide chain 1,423
514/9 Cyclopeptides 730
514/8 Glycoprotein (carbohydrate containing) 2,102
514/6 Heavy metal containing (e.g., hemoglobin, etc.) 461
514/3 Insulin or derivative 639
514/5 Iodine containing 44
514/7 Phosphorus containing 211
514/21 Produced by or extracted from animal tissue 2,400


Patents under this class:
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 Next

Patent Number Title Of Patent Date Issued
7498297 Medicinal uses of mu-opioid receptor agonists Mar. 3, 2009
7498035 Compounds of hydrophilic polymer-polycarboxyl oligopeptide and medicines, medical composite comprising above compound and use of above compound in medicines Mar. 3, 2009
7498025 Targeted bifunctional molecules and therapies based thereon Mar. 3, 2009
7498021 Dental products comprising bone growth enhancing peptide Mar. 3, 2009
7495030 (5-(2-hydroxy-4-chlorobenzoyl) aminovaleric acid and salts thereof and compositions containing the same for delivering active agents Feb. 24, 2009
7494978 Peptides acting as both GLP-1 receptor agonists and glucagon receptor antagonists and their pharmacological methods of use Feb. 24, 2009
7494973 Therapeutic fibrin-derived peptides and uses thereof Feb. 24, 2009
7494972 Method for inhibiting accelerated atherosclerosis in a subject suffering from hypercholesterolemia or hypertriglyceridemia Feb. 24, 2009
7494971 Pharmaceutical preparations and medicines capable of generating, and/or containing, thrombin Feb. 24, 2009
7494970 Cell calcification suppressing proteins, and genes of the proteins Feb. 24, 2009
7494969 Heterocarpine, a plant-derived protein with anti-cancer properties Feb. 24, 2009
7494669 Delivery of physiological agents with in-situ gels comprising anionic polysaccharides Feb. 24, 2009
7494661 Methods for using tetanus toxin for beneficial purposes in animals (mammals) Feb. 24, 2009
7494645 Lipid phosphate phosphatases and uses thereof for treating neuronal diseases Feb. 24, 2009
7491706 Artificial cpg single-stranded oligodeoxynucleotide and antiviral use thereof Feb. 17, 2009
7491701 Peptides that bind to HSP90 proteins Feb. 17, 2009
7491697 Muteins of fibroblast growth factor 21 Feb. 17, 2009
7491696 Proteolysis resistant active VEGF Feb. 17, 2009
7491693 HDL for the treatment of stroke and other ischemic conditions Feb. 17, 2009
7491692 Methods for making and delivering Rho-antagonist tissue adhesive formulations to the injured mammalian central and peripheral nervous systems and uses thereof Feb. 17, 2009
7491691 Connective tissue stimulating peptides Feb. 17, 2009
7491690 Self-assembly and mineralization of peptide-amphiphile nanofibers Feb. 17, 2009
7491689 Compositions comprising the biologically active peptide YSL Feb. 17, 2009
7491396 Process for the preparation of hypoallergenic mosaic antigens Feb. 17, 2009
7491394 Cytotoxic factors for modulating cell death Feb. 17, 2009
7488717 Methods of inhibiting chemokine binding to chemokine receptors Feb. 10, 2009
7488716 Peptides acting as both GLP-1 receptor agonists and glucagon receptor antagonists and their pharmacological methods of use Feb. 10, 2009
7488715 Peptides acting as both GLP-1 receptor agonists and glucagon receptor antagonists and their pharmacological methods of use Feb. 10, 2009
7488714 Peptides acting as both GLP-1 receptor agonists and glucagon receptor antagonists and their pharmacological methods of use Feb. 10, 2009
7488711 Use of calreticulin and calreticulin fragments to inhibit endothelial cell growth and angiogenesis, and suppress tumor growth Feb. 10, 2009
7488710 SFRP and peptide motifs that interact with SFRP and methods of their use Feb. 10, 2009
7488478 Methods and compositions for treatment of inflammatory disease using cadherin-11 modulating agents Feb. 10, 2009
7485619 Antimicrobial agent Feb. 3, 2009
7485618 FGF-5 supported and binding peptides Feb. 3, 2009
7485617 Osteoinductive materials Feb. 3, 2009
7485616 Methods of investigating, diagnosing, and treating amyloidosis Feb. 3, 2009
7485321 Peyer's patch and/or M-cell targeting ligands Feb. 3, 2009
7485304 Non-toxic mucosal adjuvant Feb. 3, 2009
7485301 Methods of treating inflammatory disease using antibodies which bind GPR-9-6 Feb. 3, 2009
7482329 Single domain TDF-related compounds and analogs thereof Jan. 27, 2009
7482326 Endothelial-monocyte activating polypeptide III Jan. 27, 2009
7482322 Plexin family-like polypeptide, and uses thereof Jan. 27, 2009
7482320 Modulation of smooth muscle cell proliferation Jan. 27, 2009
7482319 Vault and vault-like carrier molecules Jan. 27, 2009
7482318 Protein kinase domain of the large subunit of herpes simplex type 2 ribonucleotide reductase (icp 10pk) has anti-apoptotic activity Jan. 27, 2009
7482139 Variants of antithrombin III Jan. 27, 2009
7482018 Use of oligomers and polymers for drug solubilization, stabilization, and delivery Jan. 27, 2009
7482014 Melanoma therapy Jan. 27, 2009
7482009 Non-anaphylactic forms of grass pollen Phl p 6 allergen and their use Jan. 27, 2009
7482008 Human T cell reactive feline protein (TRFP) isolated from house dust and uses therefor Jan. 27, 2009

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 Next










 
 
  Recently Added Patents
Method and system for utilizing native ethernet as a virtual memory interconnect
Electronic device package and fabrication method thereof
Emergency whistle, flashlight, and compass
Wound dressing with a discontinuous contact layer surface
Charged particle source with multiple selectable particle emitters
Method for computing an energy efficient route
Establishing a graphical user interface (`GUI`) theme
  Randomly Featured Patents
Mounting arrangement for vehicle door handle
Biofilm-inhibiting effect and anti-infective activity of N,C-linked aryl isoquinolines and the use thereof
Photographic printer with dichroic filter reset indicators
Method for parallel processing of dram read request in a memory-cache controller system
CMOS image sensor and method of manufacturing the same
Methods of manufacturing semiconductor devices including forming (111) facets in silicon capping layers on source/drain regions
Stake driving and pulling attachment for a slide hammer
Therapeutic hybrid implantable devices
Lubricating oil seal device for rotating shaft bearings
Image processing method and apparatus for automatically attaching a designated text/graph on an image